- Home
- PRLD vs AKYA Comparison
PRLD vs AKYA Comparison
Compare PRLD & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- AKYA
- Stock Information
- Founded
- PRLD 2016
- AKYA 2015
- Country
- PRLD United States
- AKYA United States
- Employees
- PRLD N/A
- AKYA N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- AKYA Medical Specialities
- Sector
- PRLD Health Care
- AKYA Industrials
- Exchange
- PRLD Nasdaq
- AKYA Nasdaq
- Market Cap
- PRLD 50.1M
- AKYA 56.1M
- IPO Year
- PRLD 2020
- AKYA 2021
- Fundamental
- Price
- PRLD $0.88
- AKYA $1.26
- Analyst Decision
- PRLD Strong Buy
- AKYA Hold
- Analyst Count
- PRLD 2
- AKYA 7
- Target Price
- PRLD $4.50
- AKYA $2.51
- AVG Volume (30 Days)
- PRLD 168.1K
- AKYA 265.5K
- Earning Date
- PRLD 08-11-2025
- AKYA 08-04-2025
- Dividend Yield
- PRLD N/A
- AKYA N/A
- EPS Growth
- PRLD N/A
- AKYA N/A
- EPS
- PRLD N/A
- AKYA N/A
- Revenue
- PRLD $7,000,000.00
- AKYA $79,961,000.00
- Revenue This Year
- PRLD N/A
- AKYA $7.26
- Revenue Next Year
- PRLD N/A
- AKYA $11.44
- P/E Ratio
- PRLD N/A
- AKYA N/A
- Revenue Growth
- PRLD N/A
- AKYA N/A
- 52 Week Low
- PRLD $0.61
- AKYA $0.93
- 52 Week High
- PRLD $6.80
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- PRLD 48.33
- AKYA 52.71
- Support Level
- PRLD $0.85
- AKYA $1.21
- Resistance Level
- PRLD $1.25
- AKYA $1.35
- Average True Range (ATR)
- PRLD 0.10
- AKYA 0.08
- MACD
- PRLD -0.02
- AKYA 0.01
- Stochastic Oscillator
- PRLD 18.52
- AKYA 60.71
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.